Claire Babineaux-Fontenot

This profile gathers the share dealings of Claire Babineaux-Fontenot across 2 companies, led by Abbott Laboratories and Charah Solutions, Inc. We count 6 filings; the first trade dates from 18 June 2018 and the latest from 24 April 2026.

Every open-market trade on record is a purchase: 1 purchase worth €26k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 5 share grants.

On 28 April 2026 came the latest disclosure, a share grant in Abbott Laboratories. The clock since the last published purchase (20 June 2018) now reads 3,064 days. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.